Association between blood lead and the risk of amyotrophic lateral sclerosis.
The authors conducted a 2003-2007 case-control study including 184 cases and 194 controls to examine the association between blood lead and the risk of amyotrophic lateral sclerosis (ALS) among US veterans and to explore the influence on this association of bone turnover and genetic factors related to lead toxicokinetics. Blood lead, plasma biomarkers of bone formation (procollagen type 1 amino-terminal peptide (PINP)) and resorption (C-terminal telopeptides of type 1 collagen (CTX)), and the K59N polymorphism in the delta-aminolevulinic acid dehydratase gene, ALAD, were measured. Odds ratios and 95% confidence intervals for the association of blood lead with ALS were estimated with unconditional logistic regression after adjustment for age and bone turnover. Blood lead levels were higher among cases compared with controls (P < 0.0001, age adjusted). A doubling of blood lead was associated with a 1.9-fold increased risk of ALS (95% confidence interval: 1.3, 2.7) after adjustment for age and CTX. Additional adjustment for PINP did not alter the results. Significant lead-ALS associations were observed in substrata of PINP and CTX levels. The K59N polymorphism in the ALAD gene did not modify the lead-ALS association (P = 0.32). These results extend earlier findings by accounting for bone turnover in confirming the association between elevated blood lead level and higher risk of ALS.
Fang
Fang
F
Epidemiology Branch, National Institute of Environmental Health Sciences, National Institutes of Health, Department of Health and Human Services, Research Triangle Park, North Carolina, USA.
Kwee
Lydia C
LC
Allen
Kelli D
KD
Umbach
David M
DM
Ye
Weimin
W
Watson
Mary
M
Keller
Jean
J
Oddone
Eugene Z
EZ
Sandler
Dale P
DP
Schmidt
Silke
S
Kamel
Freya
F
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000690:Amyotrophic Lateral Sclerosis / Q000097:blood / Q000453:epidemiology* / Q000235:genetics; D015415:Biomarkers; D001862:Bone Resorption / Q000150:complications / Q000453:epidemiology; D001842:Bone and Bones / Q000378:metabolism; D016022:Case-Control Studies; D016001:Confidence Intervals; D004781:Environmental Exposure / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007854:Lead / Q000097:blood*; D007855:Lead Poisoning / Q000097:blood / Q000150:complications; D016015:Logistic Models; D008297:Male; D008875:Middle Aged; D016017:Odds Ratio; D010012:Osteogenesis; D000623:Porphobilinogen Synthase / Q000235:genetics; D012042:Registries; D012307:Risk Factors; D011795:Surveys and Questionnaires; D014481:United States / Q000453:epidemiology; D014728:Veterans / Q000706:statistics & numerical data
D015415:Biomarkers; D007854:Lead; D000623:Porphobilinogen Synthase
Environ Health Perspect. 2003 Aug;111(10):1335-9
12896855
Neuroepidemiology. 2005;24(3):141-50
15650320
Toxicology. 1999 Jul 15;135(2-3):77-85
10463764
Am J Epidemiol. 2004 Jul 1;160(1):26-33
15229114
Toxicol Lett. 1998 Dec 28;102-103:363-7
10022280
Amyotroph Lateral Scler Other Motor Neuron Disord. 2000 Dec;1(5):293-9
11464847
Am J Epidemiol. 1986 May;123(5):790-9
3962963
Ann Neurol. 2009 Jan;65 Suppl 1:S3-9
19191304
Epidemiology. 2002 May;13(3):311-9
11964933
Environ Health Perspect. 2001 Aug;109(8):827-32
11564619
Neurodegener Dis. 2005;2(3-4):195-201
16909025
Toxicology. 1988 Apr;49(1):35-41
3376124
Am J Epidemiol. 1996 Oct 15;144(8):749-59
8857824
Neurology. 2003 Sep 23;61(6):750-6
14504316
Neurology. 2003 Sep 23;61(6):742-9
14504315
J Neurol Neurosurg Psychiatry. 1970 Dec;33(6):877-85
5497881
Cancer Epidemiol Biomarkers Prev. 2007 Oct;16(10):2072-6
17932355
Am J Epidemiol. 2001 Jul 1;154(1):1-13
11427399
Neuroepidemiology. 2008;30(3):180-90
18421218
Environ Health Perspect. 2000 Mar;108 Suppl 1:23-8
10698721
Mil Med. 2008 Feb;173(2):182-6
18333495
Am J Epidemiol. 1997 Jun 15;145(12):1076-88
9199537
Neuroepidemiology. 1999;18(4):194-202
10364720
Br J Ind Med. 1992 Nov;49(11):791-8
1463680
Neurology. 1976 Feb;26(2):167-72
946326
J Neurol Neurosurg Psychiatry. 1993 Nov;56(11):1200-6
8229031
Neuroepidemiology. 2008;30(3):191-204
18421219
Cancer Epidemiol Biomarkers Prev. 2006 Sep;15(9):1742-5
16985039
Am J Epidemiol. 2000 Jan 15;151(2):156-63
10645818
Neurology. 1991 Jul;41(7):1077-84
2067636
Ann Clin Res. 1981 Apr;13(2):102-7
7235610
Neurology. 2005 Jan 11;64(1):32-7
15642900
Neuroepidemiology. 1986;5(1):29-38
3748267